Rating Change
Canaccord Genuity analysts initiated coverage on Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) with a rating of Buy on October 26, 2026.
new coverageNASDAQ:TNXP
Canaccord Genuity Initiates Coverage on Tonix Pharmaceuticals Holding Corp. (TNXP) with Buy
Canaccord Genuity analysts initiated coverage on Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) with a rating of Buy on October 26, 2026.
At publication ·
What changed
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) · new coverage
- Firm
- Canaccord Genuity
- Rating
- Buy
- Price at event
- $5.28
- Market capitalization
- $172.1M
At a glance
Key takeaways
- Canaccord Genuity initiated Buy coverage on Tonix Pharmaceuticals (TNXP) on October 26, 2026, while the stock trades at $5.28 with a $172.1M market capitalization.
Market Context
Tonix Pharmaceuticals Holding Corp. operates in the Healthcare sector. The stock currently trades at $5.28 with a market capitalization of $172.1M.
Analyst coverage from Canaccord Genuity provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Tonix Pharmaceuticals Holding Corp.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Tonix Pharmaceuticals Holding Corp.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 26, 2026 | Canaccord Genuity | Buy | N/A |
| Jun 25, 2026 | Raymond James | Strong Buy | N/A |
| May 04, 2026 | TD Cowen | Buy | N/A |
| Mar 20, 2025 | Noble Capital Markets | Outperform | N/A |
| Jul 22, 2024 | Alliance Global Partners | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View TNXP Stock Page
Frequently Asked Questions
What does the Buy rating mean for TNXP?
A rating of Buy from Canaccord Genuity reflects the analyst's outlook on Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the TNXP forecast page.